Home › Proteinuria › Massachusetts
Proteinuria clinical trials in Massachusetts
4 studies for Proteinuria are looking for participants at sites in Massachusetts.
Cities in Massachusetts
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
- Brigham and Womens Hosp Harvard Med School, Boston
RecruitingPhase 2
Ages 18 to 100 · All sexes · Updated Oct 1, 2026 · NCT05268289A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
- Investigator Site #24, Worcester
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT07268638Sparsentan for the Treatment of VEGF Signaling Pathway Inhibitor-Associated Proteinuria
- Brigham and Women's Hospital, Boston
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 30, 2026 · NCT07224776Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
- Massachusetts General Hospital, Boston
- Boston Univ School of Medicine, Boston
RecruitingPhase 3
Ages 12 to 60 · All sexes · Updated Jul 13, 2026 · NCT05755386From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.